Adial Pharmaceuticals, Inc.

ADILNASDAQHealthcare● Active

$2.21

+$0.00(+0.00%)

Market Cap$2120813

P/E Ratio—

52W High$19

52W Low$1.31

Avg Volume125K

Open$2.27

Beta1.47

Cash on Hand Financials Revenue

Adial Pharmaceuticals, Inc. (ADIL) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ADIL · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$5.9M▲ +56.8% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$5.9M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

+56.8%

vs prior fiscal year

Latest Quarter

$4.6M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$5.9MCash on Hand

Total Debt$0Total Debt

Net Cash / Net Debt+$5.9MNet Cash Position

Cash vs Debt Ratio

Cash 100%Adial Pharmaceuticals, Inc. cash as % of market cap: 277.31%% · MCap $0BDebt 0%

Adial Pharmaceuticals, Inc. has a net cash position of $5.9M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$5.9M − $0 = +$5.9M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

ADIL annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

ADIL cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$5.9M+56.8%

Dec 31, 2024FY$3.8M+32.7%

Dec 31, 2023FY$2.8M-29.4%

Dec 31, 2022FY$4.0M-34.0%

Dec 31, 2021FY$6.1M+37.7%

ADIL cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

ADIL vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Adial Pharmaceuticals, Inc.YOU

ADIL

$5.9M$2M277.3%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Adial Pharmaceuticals, Inc. (ADIL) cash on hand as of December 31, 2025 is $5.9M, comprising $5.9M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Adial Pharmaceuticals, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Adial Pharmaceuticals, Inc. cash reserves or cash position.

Adial Pharmaceuticals, Inc. annual cash on hand history shows increased +56.8% in 2025: increased +56.8% in 2025. Adial Pharmaceuticals, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Adial Pharmaceuticals, Inc. carries total debt of $0 against cash of $5.9M, resulting in a net cash position of +$5.9M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

ADIL cash on hand · 5 questions

As of December 31, 2025, Adial Pharmaceuticals, Inc. (ADIL) has $5,881,217 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $5,881,217 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $4,584,100. Data sourced from the annual 10-K filing via FMP.

ADIL cash on handADIL cash reservesADIL cash 2025how much cash does ADIL have

▸ Source: FMP /balance-sheet-statement · US GAAP · Adial Pharmaceuticals, Inc. · Adial Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025